The oncology landscape has never been more complex – or more promising. With therapeutic modalities expanding from small molecules to cell therapies, bispecific antibodies and cancer vaccines, the field is increasingly fragmented across platforms, geographies and development stages. For BD&L managers and CEOs, tracking relevant innovation requires a systematic approach. Here’s a practical guide to navigating oncology data with the help of Biotechgate.
Finding Oncology-Focused Companies
Start with the Companies section. Use the “Therapeutic area & pipeline” subsection and select “Neoplasms / cancer / oncology”. You can also choose from a variety of specific indications such as triple-negative breast cancer or pancreatic cancer.
To understand the geographic distribution of competitors or partners, use the Map Search feature on the results page. This allows you to visualize oncology clusters in specific regions and click through for detailed company profiles.
Tracking Assets and Clinical Trials
Once you’ve identified key companies, dive into their pipelines. Biotechgate offers enriched data linking, allowing you to view a company’s therapeutic assets alongside their corresponding clinical trials. You can search for trials with filters such as intervention type, phase or geography.
For a thematic search, use the Assets section. If cancer vaccines are your focus, for example, filter for oncology under “Diseases” and then select Vaccines under “Type”. The platform will return a list of relevant assets, detailing their development status, licensing status and partners (where applicable).
Actioning Data for BD and Competitive Intelligence
Finding the data is only half the battle. The real value lies in how you action it. Use Biotechgate’s advanced filters and categorization to build dynamic competitor profiles. You can combine it with saved searches and email alerts to ensure you are notified when a profile is updated, a new trial is added or a financing round is announced.
For business development, the platform’s M&A Transactions module and Licensing data are invaluable. This allows you to analyze recent deal structures, including upfront and milestone payments, aiding in benchmarking potential partnerships. When evaluating a target company, use the data to build a SWOT analysis based on their pipeline strengths, financial health (via funding history) and management team.
By transforming fragmented data into a structured intelligence workflow, Biotechgate empowers life sciences professionals to move from simply tracking oncology innovation to strategically acting upon it.